ClinicalTrials.gg
CompletedNCT01381588TOPUpdated May 16, 2017

The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal Women

An observational study in Osteoporosis, Postmenopausal, sponsored by GlaxoSmithKline. Completed at 1 site in Korea, Republic of. Open to female participants aged 50 Years to 79 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-05-16.

Sponsored by GlaxoSmithKline · Observational

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
1,136
Ages
50 Years to 79 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 12 studies in Osteoporosis, Postmenopausal with a site in Korea, Republic of — none open to participants now, none under way, none of them phase 3. Osteoporosis, Postmenopausal · Korea, Republic of.

Started
2010
the only one that year
Observational
3 of 12
none open now
Registered
5th of 12
by date
Lead sponsor
3 of 12
GlaxoSmithKline

Among the 12 studies in Osteoporosis, Postmenopausal with a site in Korea, Republic of, this one is the only one that started in 2010, is one of 3 observational ones, and was the 5th registered.

Osteoporosis, Postmenopausal

334 studies on the registry are indexed under Osteoporosis, Postmenopausal; 28 are open to participants now.

Browse Osteoporosis, Postmenopausal studies →

Open to participants now

None of the 12 studies in Osteoporosis, Postmenopausal with a site in Korea, Republic of is open now. The open studies under Osteoporosis, Postmenopausal, anywhere →

Who these studies take

Of the 19 Osteoporosis, Postmenopausal studies recruiting now, 8 (42%) set no upper age limit and 7 (37%) stop at 75 or younger; 1 takes children under 18; 7 take healthy volunteers.

This study: 50 Years to 79 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 12 studies in Osteoporosis, Postmenopausal with a site in Korea, Republic of as a file.
02

Study summary

This is an observational study to investigate the prevalence of osteoporotic fractures in post menopausal patients. Post menopausal patients who visit OS(orthopedic surgery) including GHs(general hospitals) and clinics will be enrolled.

Read the detailed description

This is an observational study to investigate the prevalence of osteoporotic fractures in post menopausal patients. Post menopausal patients who visit OS(orthopedic surgery) including GHs(general hospitals) and clinics will be enrolled. They will take the evaluation of spine X-ray and answer to a few questions. Their medical record will be reviewed and relevant clinical findings will be collected.

03

Conditions studied

  • Osteoporosis, Postmenopausal
04

Who can participate

Ages eligible
50 Years to 79 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Postmenopausal women

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subjects who were diagnosed post menopausal state
  • Subjects over 50 years old
  • The Definition of Post Menopause Women : Women whose last menstruation was over 12months ago
  • Subjects who visit orthopedic surgery
  • Subjects who have informed consents

Exclusion criteria

Exclusion Criteria:

  • Subjects who are not confirmed as post menopause state
  • Subjects who do not understand the contents of questionnaire
  • Subjects over 80 years old
  • Subjects experienced any high energy fracture (including trash and fall) within 3 months.
  • Subjects experienced a fracture except vertebral fracture within 6 months
  • Unable to evaluate L-spine BMD over 2 levels because of spinal fracture or instrumentation for L-spine 1-4.
  • Unable to evaluate BMD at both femur because of hip fracture or instrumentation.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
1,136 participants (actual)

Groups and cohorts

  • Post menopausal women

    Post menopausal women between 50 to 80

    Other: Fracture evaluation

Interventions

  • OtherFracture evaluation

    DEXA(Dual-energy X-ray absorptiometry), X-ray

    Also known as: X-ray

06

What researchers measure

Primary outcomes

  1. The prevalence of OVCFs confirmed by history and X-ray

    Time frame: 1 day

Secondary outcomes

  1. The prevalence of asymptomatic (or missed) fractures

    Time frame: 1 day

07

Study locations

1 site
  • GSK Investigational Site
    Seoul, 120-752, Korea, Republic of
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Oct 2010, a primary completion of Feb 2011 and a completion of Feb 2011. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 9, 2011
First posted
Jun 27, 2011
Start
Oct 2010
Primary completionActual
Feb 2011
CompletionActual
Feb 2011
Last update
May 16, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 16, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01381588
Lead sponsor
GlaxoSmithKline
Responsible party
Sponsor
First posted
Jun 27, 2011
Start date
Oct 2010
Primary completion
Feb 2011
Completion
Feb 2011
Last update
May 16, 2017

Study contacts

GSK Clinical Trials
study director · GlaxoSmithKline

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion